Shots:
Nyxoah announced the first patient implantation in BREATHE, its US post-approval study evaluating the long-term safety and effectiveness of the Genio System in adults with moderate to severe obstructive sleep apnea (OSA)
The prospective, multicenter study plans to implant up to 229 pts. across up to 25 US centres, with follow-up for up to…
